Rare diseases
Investigational molecules
Locations
Back to Czechia1 217 clinical trials in Prague, Czechia across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease
CzechiaStudy of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer
CzechiaStudy of Niraparib and Dostarlimab for Children with Recurrent or Hard-to-Treat Solid Tumors
CzechiaStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
CzechiaStudy on Long-Term Safety of Itepekimab for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
CzechiaStudy on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis
CzechiaStudy of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma
CzechiaLong-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks
CzechiaStudy on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
CzechiaStudy on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy
CzechiaStudy on Midostaurin and Chemotherapy for Children with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on TTR amyloidosis and heart disease treatments, alongside studies investigating hypertriglyceridemia management with novel therapeutics.
Multiple trials evaluating new therapeutic approaches for heart failure prevention and treatment.
Comprehensive studies in prostate cancer and multiple myeloma, with particular focus on metastatic conditions and novel treatment combinations.
Advanced trials comparing innovative therapies against standard treatments in various cancer types.
Extensive vaccine development programs including meningococcal and chickenpox vaccines, alongside studies in immune system disorders.
Focus on immunogenicity and safety in various age groups from infants to adults.
Research into chronic rhinosinusitis and COPD, along with studies on inflammatory bowel conditions.
Evaluating new therapeutic approaches for chronic respiratory and inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
